2012•European Journal of EndocrinologyRequires access

Etomidate in the emergency management of hypercortisolemia

Lip Min Soh, Kirun Gunganah, Scott Alexander Akker, Philip Jones, Hasanin Khachi, Kumbirai Dodzo, William Martyn Drake

Abstract

We describe a protocol for etomidate infusion for the emergency management of hypercortisolemia. Etomidate is commenced at 2.5 mg/h and titrated subsequently according to cortisol levels. It is well tolerated without any sedative effects and can be administered safely via peripheral access for use in the general ward setting.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Etomidate, Hypercortisolemia, Medicine, Anesthesia, Sedative, Internal medicine, Hydrocortisone, Propofol